Identified Pipeline Expands 30%, as Anticipated Focus on Competition and Vendor Diversity Strengthen York’s Position for Future Awards
($ in thousands, except percentages) | For the three months ended | ||||||||||
| 2026 |
| 2025 |
| % Change | ||||||
Revenue | $ | 84,171 |
|
| $ | 90,763 |
|
| (7 | )% | |
Gross profit |
| 15,519 |
|
|
| 20,266 |
|
| (23 | )% | |
Net loss |
| (807,398 | ) |
|
| (20,081 | ) |
| 3921 | % | |
Adjusted EBITDA (non-GAAP) | $ | (27,575 | ) |
| $ | (3,399 | ) |
| 711 | % | |
($ in thousands, except percentages) | For the nine months ended | ||||||||||
| 2026 |
| 2025 |
| % Change | ||||||
Revenue | $ | 293,061 |
|
| $ | 280,854 |
|
| 4 | % | |
Gross profit |
| 59,849 |
|
|
| 54,394 |
|
| 10 | % | |
Net loss |
| (961,583 | ) |
|
| (56,044 | ) |
| 1616 | % | |
Adjusted EBITDA (non-GAAP) | $ | (40,716 | ) |
| $ | (6,864 | ) |
| 493 | % | |
* See definition and reconciliation of Adjusted EBITDA to net loss under “Non-GAAP Financial Measures” and “Reconciliation of GAAP to Non-GAAP Measures.” | |||||||||||
York also announced today that
“Our identified pipeline grew more than 30 percent compared to last quarter, and we have secured the critical contract positions needed to compete for significant awards in 2027 and beyond, with IDIQ awards already converting into funded task orders,” said
“Our contribution margins continue to benefit from the shift to newer programs, and we see a long-term trend toward increased profitability as we move up the value chain," said
Third Quarter 2026 Company Results
Revenue for the quarter was
Gross Margin was 18% in the current year quarter, down 400 bps from last year’s Q3; Gross Profit was
York recorded a non-cash goodwill impairment charge of
Backlog stood at
Selected Third Quarter and Recent Highlights
- York secured two task orders supporting the
U.S . Space Force’s Space Data Network (SDN), advancing multi-vendor interoperability demonstrations andSpace Exchange Point development. The awards build on York’s SDN contract position and demonstrate the opportunity to apply its spacecraft payload integration and ground infrastructure capabilities as the government develops scalable, interoperate space communications architectures.
- York was selected for the
U.S . Space Force’s NITE-STAR IDIQ contract, expanding its opportunity to support space test and training missions. The contract positions York to compete for task orders combining its spacecraft platforms with ATLAS’s global ground network to deliver integrated capabilities that help Space Force operators train against real-world threats.
- York introduced LX/V-CLASS, a spacecraft platform purpose-built for Very Low Earth Orbit (VLEO), to address growing government and commercial demand for higher-fidelity observation and resilient orbit diversity in VLEO, one of the fastest-growing operational domains in space. The platform expands York’s addressable mission opportunities, drawing on its flight-proven spacecraft and established production infrastructure to meet demand for rapidly deployable, proliferated constellations at scale.
- York expanded into Geosynchronous Earth Orbit (GEO) through the
U.S . Space Force’s Tetra 3 and 4 missions, referred to by York as Nemesis, broadening the company’s opportunity to support growing government demand for Space Domain Awareness missions beyond LEO. As prime contractor, York is applying its spacecraft design, sensor integration, and mission execution capabilities to these missions, with spacecraft delivery targeted for the fourth quarter of this year.
- ALL.SPACE, a wholly owned subsidiary of York, and
NAVSYS demonstrated resilient communications and alternative position, navigation, and timing in a fully GPS-denied environment during the military’s Arcane Thunder exercise. Combining ALL.SPACE’s Hydra terminal with NAVSYS’s PNT-as-a-Service, the demonstration highlights the opportunity to address defense requirements for assured connectivity and navigation in contested environments through a single, integrated platform.
- York and ATLAS, a wholly owned subsidiary of York, activated a second antenna in Mwulire,
Rwanda , doubling the site’s simultaneous satellite contact capacity to meet growing demand for equatorial coverage. The addition expands capacity for existing missions and new customers, strengthening York’s global ground infrastructure and its ability to support government and commercial constellations through its integrated ecosystem.
- York identified Tomorrow.io as the customer behind its previously announced
$187 million commercial contract, under which York will serve as prime contractor for the initial phase of the DeepSky early warning constellation. The program calls for dozens of satellites built on York’s M-CLASS platform.
- In October, York opened a larger
Austin office to support its growing software team and development of capabilities for satellite constellations and future unmanned operations. The facility strengthens York’s ability to attract technical talent and advance the integrated systems needed to connect and coordinate distributed assets across space, land, sea, and air.
- In October, ALL.SPACE secured an order from Viasat for multiple Hydra MAX terminals, demonstrating continued commercial momentum and growing government and defense demand for resilient, multi-orbit communications. Approved to operate on Viasat’s global NextGen Ka-band network, Hydra MAX expands access to assured connectivity for mobile users while supporting York’s broader opportunity to connect crewed and unmanned platforms across contested environments.
- In November, ALL.SPACE announced follow-on
U.S. Navy orders for 59 Hydra MAX 2 terminals, bringing the Navy’s total procurement to 108 systems, with combined orders valued at more than$25 million . The orders demonstrate continued customer confidence and demand for resilient, multi-orbit communications, reinforcing the opportunity to expand adoption of York’s integrated communications capabilities across crewed platforms and future unmanned fleets.
- In November, York shared that it will be working with Terma to combine York’s spacecraft platforms and manufacturing capacity with Terma’s space electronics and software expertise. The collaboration broadens York’s international opportunities, particularly in
Europe , where Terma’s established relationships can open access to markets increasingly seeking sovereign space capabilities aligned with their national priorities.
- In November, Orbion, a wholly owned subsidiary of York, announced a partnership with ENPULSION to bring its flight-proven Hall-effect propulsion systems to European satellite manufacturers, expanding propulsion options and simplifying integration for a wider range of missions. The collaboration supports York’s expansion into
Europe , creating opportunities for customers to draw on its broader ecosystem of spacecraft platforms, global ground infrastructure, software, and mission operations capabilities.
- In November, York announced its intent to acquire
Outlook Industries , establishing the planned foundation for York Terrestrial Systems and extending its proven space, ground, communications, and software ecosystem to unmanned platforms in the field. The proposed acquisition would open access to an established$3.08 billion unmanned ground systems market and position York to pursue opportunities in the estimated$10.31 billion unmanned surface and underwater vessel markets, supporting demand for integrated autonomous fleets while keeping warfighters farther from the fight.
Liquidity
As of
Business Outlook as of
We are working on a pipeline of government opportunities worth
Business outlook is based on information as of today,
Conference Call
York will host a conference call to review its financial results for the third quarter of 2026 and its outlook for the future and may disclose other material developments affecting its business and/or financial performance. Listeners may access the conference call live via audio webcast.
Webcast: https://events.q4inc.com/attendee/739520037
York’s financial results release will be available after the close of market on
About
Forward-Looking Statements
This presentation contains “forward-looking statements” within the meaning of, and the Company intends such forward-looking statements to be covered by, the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. Forward-looking statements are inherently subject to risks and uncertainties, some of which cannot be predicted or quantified. In some cases, you can identify forward-looking statements by terminology such as “anticipate,” “believe,” “continue,” “could,” “estimate,” “expect,” “intend,” “may,” “might,” “objective,” “ongoing,” “plan,” “predict,” “project,” “potential,” “should,” “will,” “would,” or the negative of these terms or other comparable terminology. In particular, statements about our contract awards trends and related regulatory developments, including statements about future task orders and opportunities related to awards under the Indefinite Quantity Indefinite Delivery methodology and the conversion of IDIQ awards into funded task orders, the timing and size of awards we expect to compete for in 2027, expectations regarding our pipeline, expectations regarding government agencies, programs and actions, our market opportunity, addressable market and the potential growth of that market, our M&A strategy, the proposed acquisition of
Factors that could cause actual results to differ materially from those expressed or implied by the forward-looking statements include: disruptions in
Non-GAAP Financial Measures
We believe that in addition to our results determined in accordance with
These non-GAAP financial measures are used to supplement the financial information presented on a GAAP basis and should not be considered in isolation or as a substitute for the relevant GAAP measures and should be read in conjunction with information presented on a GAAP basis. Because not all companies use identical calculations, our presentation of non-GAAP measures may not be comparable to other similarly titled measures of other companies.
Non-GAAP financial measures are limited in value because they exclude certain items that may have a material impact on our reported financial results. In addition, they are subject to inherent limitations as they reflect the exercise of judgments by management about which items are adjusted to calculate our non-GAAP financial measures. We compensate for these limitations by analyzing current and future results on a GAAP basis as well as a non-GAAP basis and also by providing GAAP measures in our public disclosures.
Contribution Margin
We refer to revenue less direct material costs of revenue as “contribution margin” and contribution margin divided by revenue as “contribution margin %.” The closest comparable GAAP financial measures to contribution margin and contribution margin % are gross profit and gross profit margin %, respectively. We believe contribution margin and contribution margin % are useful measures of the variable costs that we incur in order to provide services to our customers. Our presentation of contribution margin and contribution margin % should not be construed as an inference that our future results will be unaffected by variable costs.
EBITDA and Adjusted EBITDA
We define EBITDA as net income (loss) adjusted for interest expense, interest income, income tax benefit, and depreciation and amortization. Adjusted EBITDA is defined as EBITDA adjusted for changes in the fair value of derivatives, loss on debt extinguishment, transaction costs, and other non-recurring items. Net loss is the most directly comparable GAAP measure to Adjusted EBITDA. Our presentation of EBITDA and Adjusted EBITDA should not be construed as an inference that our future results will be unaffected by unusual or non-recurring items.
For more information on our non-GAAP financial measures and a reconciliation of GAAP to non-GAAP measures, see the “Reconciliation of GAAP to Non-GAAP Results” table in this press release.
Backlog
We view backlog as a key measure of our business growth. Backlog represents our estimate of the revenue we expect to realize in future periods as a result of performing work on contracts that have been awarded to us (net of any revenue already recognized as of the backlog date). We include the aggregate expected revenue of awarded contracts in our backlog upon the execution of a legally binding agreement, even though our contracts include certain termination rights exercisable by our customers with advance notice. We exclude unexercised contract options from our backlog. Contract liabilities recognized on our consolidated balance sheets consists of payments and billings that we have received in excess of revenue that we have recognized. Because cash receipts from these contracts have not been recognized into revenue, they are included in our backlog calculation.
We monitor our backlog because we believe it is a forward-looking indicator of potential sales which can be helpful to investors in evaluating the performance of our business and identifying trends over time. Although backlog reflects business associated with contracts that are considered to be firm, terminations, amendments, or contract cancellations may occur, which could result in a reduction in our total backlog and potential future revenue that is never recognized.
APPENDIX - 1
Condensed Consolidated Statements of Operations and Comprehensive Loss (Unaudited) | ||||||||||||||||
| For the three months ended |
| For the nine months ended | |||||||||||||
($ in thousands, except shares and per share amounts) | 2026 |
| 2025 |
| 2026 |
| 2025 | |||||||||
Revenue | $ | 84,171 |
|
| $ | 90,763 |
| $ | 293,061 |
|
| $ | 280,854 |
| ||
Cost of revenues |
| 68,652 |
|
|
| 70,497 |
|
| 233,212 |
|
|
| 226,460 |
| ||
Gross profit |
| 15,519 |
|
|
| 20,266 |
|
| 59,849 |
|
|
| 54,394 |
| ||
Operating expenses |
|
|
|
|
|
| ||||||||||
Selling, general and administrative expenses |
| 50,276 |
|
|
| 31,532 |
|
| 127,807 |
|
|
| 84,123 |
| ||
Stock compensation expense |
| 7,874 |
|
|
| — |
|
| 103,463 |
|
|
| — |
| ||
Research and development expenses |
| 9,521 |
|
|
| 4,502 |
|
| 20,576 |
|
|
| 13,796 |
| ||
Transaction costs |
| 6,564 |
|
|
| 9,896 |
|
| 18,498 |
|
|
| 10,002 |
| ||
| 749,737 |
|
|
| — |
|
| 749,737 |
|
|
| — |
| |||
Total operating expenses |
| 823,972 |
|
|
| 45,930 |
|
| 1,020,081 |
|
|
| 107,921 |
| ||
Loss from operations |
| (808,453 | ) |
|
| (25,664 | ) |
| (960,232 | ) |
|
| (53,527 | ) | ||
Other (expense) income |
|
|
|
|
|
| ||||||||||
Interest expense |
| (2,969 | ) |
|
| (7,208 | ) |
| (8,752 | ) |
|
| (21,385 | ) | ||
Interest income |
| 3,244 |
|
|
| 276 |
|
| 12,072 |
|
|
| 1,035 |
| ||
Other income (expense), net |
| (140 | ) |
|
| 595 |
|
| (5,419 | ) |
|
| 1,910 |
| ||
Total other expense |
| 135 |
|
|
| (6,337 | ) |
| (2,099 | ) |
|
| (18,440 | ) | ||
Loss before provision for income taxes |
| (808,318 | ) |
|
| (32,001 | ) |
| (962,331 | ) |
|
| (71,967 | ) | ||
Income tax (expense) benefit |
| 920 |
|
|
| 11,920 |
|
| 748 |
|
|
| 15,923 |
| ||
Net loss | $ | (807,398 | ) |
| $ | (20,081 | ) | $ | (961,583 | ) |
| $ | (56,044 | ) | ||
Foreign currency translation adjustment |
| (209 | ) |
|
| 295 |
|
| (281 | ) |
|
| 1,152 |
| ||
Comprehensive loss | $ | (807,607 | ) |
| $ | (19,786 | ) | $ | (961,864 | ) |
| $ | (54,892 | ) | ||
Net loss per common share |
|
|
|
|
|
| ||||||||||
Net loss | $ | (807,398 | ) |
| $ | (20,081 | ) | $ | (961,583 | ) |
| $ | (56,044 | ) | ||
Less: Accretion of Class | $ | — |
|
| $ | — |
| $ | 192 |
|
| $ | — |
| ||
Less: Deemed dividend on Conversion of the Class | $ | — |
|
| $ | — |
| $ | 60,722 |
|
| $ | — |
| ||
Net loss available to common shareholders | $ | (807,398 | ) |
| $ | (20,081 | ) | $ | (1,022,497 | ) |
| $ | (56,044 | ) | ||
Basic and diluted net loss per share | $ | (5.99 | ) |
| $ | (0.21 | ) | $ | (8.09 | ) |
| $ | (0.59 | ) | ||
Weighted average common shares outstanding |
|
|
|
|
|
| ||||||||||
Basic and diluted weighted common shares outstanding |
| 134,688,809 |
|
|
| 95,141,928 |
|
| 126,337,519 |
|
|
| 95,141,928 |
| ||
Condensed Consolidated Balance Sheets (Unaudited) | ||||||||
($ in thousands) |
| As of |
| As of | ||||
Assets |
|
|
|
| ||||
Current assets |
|
|
|
| ||||
Cash and cash equivalents |
| $ | 308,939 |
|
| $ | 162,573 |
|
Accounts receivable, net |
|
| 29,816 |
|
|
| 11,539 |
|
Inventories |
|
| 50,903 |
|
|
| 18,747 |
|
Prepaid expenses and other current assets |
|
| 35,048 |
|
|
| 31,478 |
|
Contract assets |
|
| 150,967 |
|
|
| 76,809 |
|
Capitalized commissions, net |
|
| 3,494 |
|
|
| 6,661 |
|
Total current assets |
|
| 579,167 |
|
|
| 307,807 |
|
Fixed assets, net |
|
| 64,883 |
|
|
| 46,293 |
|
Right of use assets, net |
|
| 31,897 |
|
|
| 24,683 |
|
|
| 322,499 |
|
|
| 674,262 |
| |
Other intangibles, net |
|
| 422,296 |
|
|
| 407,925 |
|
Other assets |
|
| 5,369 |
|
|
| 14,415 |
|
Total assets |
| $ | 1,426,111 |
|
| $ | 1,475,385 |
|
Liabilities, Temporary Equity and Member's Capital/Stockholders' Equity |
|
|
|
| ||||
Current liabilities |
|
|
|
| ||||
Contract liabilities |
| $ | 41,210 |
|
| $ | 110,275 |
|
Accounts payable and accrued expenses |
|
| 101,721 |
|
|
| 68,358 |
|
Operating lease liabilities, current |
|
| 4,606 |
|
|
| 3,260 |
|
Income taxes payable |
|
| 1,001 |
|
|
| 672 |
|
Long-term debt, current |
|
| 6,563 |
|
|
| 3,750 |
|
Deferred commissions, current |
|
| 5,415 |
|
|
| 5,038 |
|
Other current liabilities |
|
| 1,657 |
|
|
| — |
|
Total current liabilities |
|
| 162,173 |
|
|
| 191,353 |
|
Operating lease liabilities, less current portion |
|
| 29,018 |
|
|
| 23,161 |
|
Deferred commissions, less current portion |
|
| 993 |
|
|
| 2,110 |
|
Long-term debt, net |
|
| 139,652 |
|
|
| 144,962 |
|
Derivative liability associated with Class |
|
| — |
|
|
| 93,411 |
|
Other liabilities |
|
| 8,686 |
|
|
| 3,353 |
|
Deferred income tax liability |
|
| 4,691 |
|
|
| 6,096 |
|
Total liabilities |
| $ | 345,213 |
|
| $ | 464,446 |
|
Commitments and contingencies |
|
|
|
| ||||
Temporary Equity |
|
|
|
| ||||
Class |
|
| — |
|
|
| 143,115 |
|
Member's Capital/Stockholders Equity |
|
|
|
| ||||
Common units (0 and 50,000,000 authorized, issued and outstanding at |
|
| — |
|
|
| 1,135,910 |
|
Common stock ( |
|
| 14 |
|
|
| — |
|
Additional paid-in-capital |
|
| 2,310,834 |
|
|
| — |
|
Accumulated other comprehensive income (loss) |
|
| 655 |
|
|
| 936 |
|
Accumulated deficit |
|
| (1,230,605 | ) |
|
| (269,022 | ) |
Total member's capital |
|
| 1,080,898 |
|
|
| 867,824 |
|
Total liabilities, temporary equity, and member's capital/stockholders' equity |
| $ | 1,426,111 |
|
| $ | 1,475,385 |
|
Condensed Consolidated Statements of Cash Flows (Unaudited) | ||||||||
|
| For the nine months ended | ||||||
($ in thousands) |
| 2026 |
| 2025 | ||||
Cash flows from operating activities |
|
|
|
| ||||
Net loss |
| $ | (961,583 | ) |
| $ | (56,044 | ) |
Adjustments to reconcile net loss to net cash (used in)/provided by operating activities: |
|
|
|
| ||||
Depreciation and amortization |
|
| 47,633 |
|
|
| 36,611 |
|
Stock compensation expense |
|
| 103,463 |
|
|
| — |
|
Amortization of debt issuance costs |
|
| 633 |
|
|
| 657 |
|
Non-cash lease expense |
|
| 3,428 |
|
|
| 1,983 |
|
Amortization of capitalized commissions |
|
| 3,126 |
|
|
| 4,016 |
|
Deferred taxes |
|
| (1,624 | ) |
|
| (13,217 | ) |
Loss on equity investments, net |
|
| 1,594 |
|
|
| (750 | ) |
Other, net |
|
| 6,207 |
|
|
| (741 | ) |
Changes in assets and liabilities, net of the effect of acquisitions: |
|
|
|
| ||||
Accounts receivable, net |
|
| (17,079 | ) |
|
| (19,468 | ) |
Inventories |
|
| (24,317 | ) |
|
| 9,175 |
|
Prepaid expenses and other current assets |
|
| 2,839 |
|
|
| 23,812 |
|
Contract assets |
|
| (74,050 | ) |
|
| (18,054 | ) |
Other assets |
|
| (442 | ) |
|
| (157 | ) |
Contract liabilities |
|
| (80,503 | ) |
|
| (79,337 | ) |
Accounts payable and accrued expenses |
|
| (3,441 | ) |
|
| 22,730 |
|
Deferred commissions |
|
| (740 | ) |
|
| (1,467 | ) |
Income taxes payable |
|
| 320 |
|
|
| — |
|
Related party payables |
|
| — |
|
|
| 1,953 |
|
Other liabilities |
|
| (335 | ) |
|
| 516 |
|
Right of use assets and operating lease liabilities, net |
|
| (3,263 | ) |
|
| (1,685 | ) |
Net cash (used in) operating activities |
|
| (248,397 | ) |
|
| (88,229 | ) |
Cash flows from investing activities |
|
|
|
| ||||
Capital expenditures |
|
| (7,620 | ) |
|
| (4,311 | ) |
Equity investments |
|
| (6,156 | ) |
|
| (5,000 | ) |
Acquisition of businesses, net of cash acquired |
|
| (183,304 | ) |
|
| (1,097 | ) |
Issuance of notes receivable |
|
| — |
|
|
| (5,000 | ) |
Proceeds from settlement of notes receivable |
|
| 5,000 |
|
|
| — |
|
Net cash (used in)/provided by investing activities |
|
| (192,080 | ) |
|
| (15,408 | ) |
Cash flows from financing activities |
|
|
|
| ||||
Proceeds from issuance of common stock in connection with the IPO, net of underwriting discounts and commissions |
|
| 592,833 |
|
|
| — |
|
Payment of offering costs in connection with the IPO |
|
| (3,192 | ) |
|
| — |
|
Repayment of principal on long-term debt |
|
| (2,813 | ) |
|
| — |
|
Proceeds from issuance of redeemable preferred units |
|
| — |
|
|
| 25,000 |
|
Net cash provided by financing activities |
|
| 586,828 |
|
|
| 21,268 |
|
Net increase/(decrease) in cash and cash equivalents |
|
| 146,351 |
|
|
| (82,369 | ) |
Effect of exchange rate changes on cash |
|
| 15 |
|
|
| 250 |
|
Cash and cash equivalents, beginning of period |
|
| 162,573 |
|
|
| 104,656 |
|
Cash at end of period |
| $ | 308,939 |
|
| $ | 22,537 |
|
Supplemental disclosures of cash flow information |
|
|
|
| ||||
Cash payments for interest |
| $ | 8,326 |
|
| $ | 18,772 |
|
Cash (refunded)/paid for taxes |
|
| (9 | ) |
|
| (2,698 | ) |
Noncash operating, investing, and financing |
|
|
|
| ||||
Non-cash contribution |
|
| — |
|
|
| 78,588 |
|
Deferred offering costs in accounts payable and accrued expenses |
|
| — |
|
|
| (2,797 | ) |
Changes in accounts payable and accruals for purchases of fixed assets |
|
| 4,308 |
|
|
| 224 |
|
Conversion of common units into shares of common stock upon IPO |
|
| 1,135,718 |
|
|
| — |
|
Conversion of Class |
|
| 241,391 |
|
|
| — |
|
Issuance of common shares for acquisition of Orbion |
|
| 60,180 |
|
|
| — |
|
Issuance of common shares for acquisition of Solestial |
|
| 51,857 |
|
|
| — |
|
Issuance of common stock for acquisition of All.Space |
|
| 134,824 |
|
|
| — |
|
APPENDIX - 2
Reconciliation of GAAP to Non-GAAP Results | ||||||||||||||||
Contribution Margin | ||||||||||||||||
(Unaudited) | ||||||||||||||||
| For the three months ended |
| For the nine months ended | |||||||||||||
($ in thousands, except percentages) | 2026 |
| 2025 |
| 2026 |
| 2025 | |||||||||
Revenue | $ | 84,171 |
|
| $ | 90,763 |
| $ | 293,061 |
|
| $ | 280,854 |
| ||
Direct material costs |
| 50,151 |
|
|
| 59,014 |
|
| 179,668 |
|
|
| 193,519 |
| ||
Contribution margin (non-GAAP) | $ | 34,020 |
|
| $ | 31,749 |
| $ | 113,393 |
|
| $ | 87,335 |
| ||
Contribution margin % (non-GAAP) |
| 40 | % |
|
| 35 | % |
| 39 | % |
|
| 31 | % | ||
Reconciliation to Contribution Margin | ||||||||||||||||
(Unaudited) | ||||||||||||||||
($ in thousands, except percentages) | For the three months ended |
| For the nine months ended | |||||||||||||
| 2026 |
| 2025 |
| 2026 |
| 2025 | |||||||||
Revenue | $ | 84,171 |
|
| $ | 90,763 |
| $ | 293,061 |
|
| $ | 280,854 |
| ||
Less: Cost of revenues |
| 68,652 |
|
|
| 70,497 |
|
| 233,212 |
|
|
| 226,460 |
| ||
Gross profit (GAAP) | $ | 15,519 |
|
| $ | 20,266 |
| $ | 59,849 |
|
| $ | 54,394 |
| ||
Gross profit % (GAAP) |
| 18 | % |
|
| 22 | % |
| 20 | % |
|
| 19 | % | ||
Add: Direct labor costs |
| 12,137 |
|
|
| 8,070 |
|
| 33,412 |
|
|
| 23,455 |
| ||
Add: Direct overhead costs |
| 4,203 |
|
|
| 1,904 |
|
| 11,282 |
|
|
| 5,288 |
| ||
Add: Depreciation and amortization |
| 2,161 |
|
|
| 1,509 |
|
| 8,850 |
|
|
| 4,198 |
| ||
Contribution margin (non-GAAP) | $ | 34,020 |
|
| $ | 31,749 |
| $ | 113,393 |
|
| $ | 87,335 |
| ||
Contribution margin % (non-GAAP) |
| 40 | % |
|
| 35 | % |
| 39 | % |
|
| 31 | % | ||
Reconciliation of Net Loss to Adjusted EBITDA | ||||||||||||||||
(Unaudited) | ||||||||||||||||
| For the three months ended |
| For the nine months ended | |||||||||||||
($ in thousands) | 2026 |
| 2025 |
| 2026 |
| 2025 | |||||||||
Net loss | $ | (807,398 | ) |
| $ | (20,081 | ) | $ | (961,583 | ) |
| $ | (56,044 | ) | ||
Interest expense |
| 2,969 |
|
|
| 7,208 |
|
| 8,752 |
|
|
| 21,385 |
| ||
Interest income |
| (3,244 | ) |
|
| (276 | ) |
| (12,072 | ) |
|
| (1,035 | ) | ||
Income tax expense (benefit) |
| (920 | ) |
|
| (11,920 | ) |
| (748 | ) |
|
| (15,923 | ) | ||
Depreciation and amortization |
| 16,644 |
|
|
| 12,350 |
|
| 47,633 |
|
|
| 36,611 |
| ||
EBITDA (non-GAAP) | $ | (791,949 | ) |
| $ | (12,719 | ) | $ | (918,018 | ) |
| $ | (15,006 | ) | ||
Changes in the fair value of derivatives |
| 62 |
|
|
| 153 |
|
| 3,775 |
|
|
| (1,243 | ) | ||
Stock-based compensation expense |
| 7,874 |
|
|
| — |
|
| 103,463 |
|
|
| — |
| ||
Transaction costs(1) |
| 6,564 |
|
|
| 9,896 |
|
| 18,498 |
|
|
| 10,002 |
| ||
749,737 | — | 749,737 | — | |||||||||||||
Other(2) |
| 137 |
|
|
| (729 | ) |
| 1,829 |
|
|
| (617 | ) | ||
Adjusted EBITDA (non-GAAP) | $ | (27,575 | ) |
| $ | (3,399 | ) | $ | (40,716 | ) |
| $ | (6,864 | ) | ||
(1) | Represents costs for legal, advisory fees and other costs incurred in connection with the Company's acquisition activity and one-time IPO costs. | |
(2) | Other includes a gain and loss on the initial investments for Solestial and Orbion, respectively, net gain on foreign exchange and one-time non-cash expense. |
Backlog | ||||||||
(Unaudited) | ||||||||
|
|
| ||||||
($ in thousands) | As of |
| As of | |||||
Backlog | $ | 580,982 |
|
| $ | 542,557 |
| |
View source version on businesswire.com: https://www.businesswire.com/news/home/20261112049211/en/
Investor Contact
ir@yorkspacesystems.com
Media Contact
Sarah.nickell@yorkspacesystems.com
Source: